New Zealand medical journal,
Год журнала:
2024,
Номер
137(1592), С. 54 - 76
Опубликована: Март 18, 2024
aim:
To
describe
the
impact
of
living
with
migraine
disease
in
Aotearoa
New
Zealand.
method:
Online
survey:
Migraine
Zealand
Survey
(MiANZ)
delivered
via
SurveyMonkey
from
22
August
2022
to
7
October
2022.
Questions
included:
socio-demographics,
Disability
Assessment
Scale
(MIDAS),
on
work
and
open-ended
questions
free
text.
Analysis
used
a
mixed
method
approach.
results:
Five
hundred
thirty
people
(82%
female;
77%
NZ
European/Other).
Almost
half
respondents
had
severe
disability,
measured
by
MIDAS.
Based
reported
headaches
days
per
month,
23%
chronic
migraine.
Significant
impacts
were
noted
all
areas
life.
Themes
rich
free-text
data
included
“physical
impacts”,
“mental
health
“impacts
(paid/unpaid)”,
social
connection”
trying
find
cause
or
cure”.
conclusion:
This
is
first
survey
shows
high
levels
disability.
Greater
awareness
needed,
among
public
workplaces,
where
more
support
accommodation
for
workers
could
have
positive
effect
productivity.
Neurobiology of Pain,
Год журнала:
2024,
Номер
16, С. 100171 - 100171
Опубликована: Июль 1, 2024
Migraine
affects
∼12
%
of
the
worldwide
population
and
is
more
prevalent
in
females,
which
suggests
a
role
sex
hormones
migraine
pathophysiology.
Most
studies
have
focused
on
estrogen
progesterone,
involvement
androgens
has
been
less
studied.
However,
due
to
recent
advances
androgen
interventions,
could
advance
new
androgen-based
treatments,
it
critical
better
understand
migraine.
Testosterone,
most
studied
androgen,
was
found
an
antinociceptive
effect
various
animal
human
pain
studies.
Thus,
also
protective
related
lower
severity
prevalence.
In
this
review,
we
discuss
examining
migraine-related
symptoms
models.
Additionally,
summarize
results
comparing
levels
between
patients
with
healthy
controls,
assessing
relationships
severity,
intervention
impact
testosterone
treatment
severity.
Many
limitations,
however,
suggest
that
may
minor
Still,
possible
are
involved
pathophysiology
sub-group
such
as
adolescents
or
postmenopausal
women.
We
potential
mechanisms
testosterone,
main
tested,
can
These
range
from
cellular
level
systems
behavior
include
sensory
neurons,
immune
vascular
systems,
stress
response,
brain
function,
mood.
Lastly,
future
directions
line
research.
The Journal of Headache and Pain,
Год журнала:
2023,
Номер
24(1)
Опубликована: Ноя. 27, 2023
Migraine
is
a
primary
headache,
which
has
been
producing
heavy
disease
burden
globally.
There
no
data
on
the
incidence
of
migraine
among
women
childbearing
age
worldwide,
including
China.
This
study
aimed
to
investigate
time
trend
in
rate
China
from
1999
2019,
and
make
prediction
for
2030.Data
population
were
derived
Global
Burden
Diseases
Study
2019.
Crude
age-standardized
rates
(CIR,
ASIR)
presented.
The
during
1990-2019
was
examined
using
annual
percent
change
average
based
Joinpoint
regression
models.
Age-period-cohort
model
introduced
estimate
independent
effect
age,
period
cohort
participants
over
three
decades.
Bayesian
age-period-cohort
analysis
conducted
predict
2030
China.For
China,
case
number,
CIR
ASIR
kept
rising,
with
cumulative
percentage
increase
10.87%,
2.01%
5.65%,
respectively,
1990
An
0.18%
observed
As
effects,
adjusted
cohort-specific
relative
risks
constantly
increased
0.91
(95%
CI:
0.90,
0.93)
1940-1949
1.04
1.03,
1.05)
1995-2004
cohort,
while
period-specific
initially
declined
1.00
0.99,
1.00)
1990-1994
0.99
0.98,
0.99)
1995-1999
then
1.04)
2015-2019
cohort.
Moreover,
age-specific
followed
bimodal
pattern
peaks
at
age-group
25-29
years
(CIR
=
1718.27/100000)
35-39
1635.18/100000).
Projection
modeling
showed
that
will
continue
significantly
2020
2030.Migraine
remained
an
increasing
2019
projected
continually
till
important
public
health
implication
population-level
prevention
Precision
intervention
strategies
approaches
shall
be
considered
campaigns
initiated
Chinese
age.
New Zealand medical journal,
Год журнала:
2024,
Номер
137(1592), С. 54 - 76
Опубликована: Март 18, 2024
aim:
To
describe
the
impact
of
living
with
migraine
disease
in
Aotearoa
New
Zealand.
method:
Online
survey:
Migraine
Zealand
Survey
(MiANZ)
delivered
via
SurveyMonkey
from
22
August
2022
to
7
October
2022.
Questions
included:
socio-demographics,
Disability
Assessment
Scale
(MIDAS),
on
work
and
open-ended
questions
free
text.
Analysis
used
a
mixed
method
approach.
results:
Five
hundred
thirty
people
(82%
female;
77%
NZ
European/Other).
Almost
half
respondents
had
severe
disability,
measured
by
MIDAS.
Based
reported
headaches
days
per
month,
23%
chronic
migraine.
Significant
impacts
were
noted
all
areas
life.
Themes
rich
free-text
data
included
“physical
impacts”,
“mental
health
“impacts
(paid/unpaid)”,
social
connection”
trying
find
cause
or
cure”.
conclusion:
This
is
first
survey
shows
high
levels
disability.
Greater
awareness
needed,
among
public
workplaces,
where
more
support
accommodation
for
workers
could
have
positive
effect
productivity.
